Allergy & Asthma Network Mothers of Asthmatics (AANMA)

Techno Medicine Shifts Costs and Risks to Patients

FDA posted a “new paradigm” for public consideration – one in which routine diagnostic and treatment decisions would shift from our physicians to patients and pharmacists and/or other technologies. FDA’s Register Notice states the aim is to reduce routine care visits, healthcare costs and free up physicians to treat more seriously ill patients.

At Allergy & Asthma Day Capitol Hill, May 9, 2013, Allergy & Asthma Network Mothers of Asthmatics held a Congressional Press Briefing to raise awareness of the FDA proposed paradigm and encourage congressional support to remove asthma and anaphylaxis medications from such consideration. On June 11, 2013, AANMA filed a Citizens Petition requesting an exemption for asthma and anaphylaxis medications from the list of over the counter (OTC) medications. Numerous professional medical societies and nonprofit patient organizations signed on to demonstrate their support of AANMA’s position. To review the petition as filed, click here.

Read more:

Public Hearing Testimony in response to FDA’s proposal:

What you can do:

  • Join AANMA to support our advocacy efforts and keep up to date on issues that affect you and your family. You’ll receive our award-winning newsletter and magazine straight to your mailbox, as well as e-mail alerts about ongoing issues.
  • Share information on this issue with friends, family and medical care providers. Print out copies of these articles or send them links to this website.
  • Bookmark AANMA’s website, www.aanma.org, and this Advocacy page and check it often for updated information on this issue and on Allergy & Asthma Day Capitol Hill 2013.